Chemours (NYSE:CC) Stock Price Up 5.6% - Still a Buy?

The Chemours Company (NYSE:CC - Get Free Report)'s stock price shot up 5.6% during trading on Tuesday . The stock traded as high as $11.98 and last traded at $12.09. 294,750 shares were traded during trading, a decline of 88% from the average session volume of 2,403,953 shares. The stock had previously closed at $11.45.

Analyst Ratings Changes

CC has been the topic of several research analyst reports. Wall Street Zen lowered Chemours from a "hold" rating to a "sell" rating in a research note on Wednesday, May 21st. Royal Bank Of Canada decreased their price objective on shares of Chemours from $17.00 to $14.00 and set an "outperform" rating for the company in a research note on Thursday, May 8th. Barclays cut their target price on shares of Chemours from $16.00 to $13.00 and set an "equal weight" rating on the stock in a research note on Wednesday, May 28th. The Goldman Sachs Group decreased their price target on shares of Chemours from $21.00 to $14.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. Finally, Morgan Stanley cut their price objective on Chemours from $22.00 to $15.00 and set an "equal weight" rating on the stock in a research report on Monday, May 12th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company. According to MarketBeat, Chemours currently has an average rating of "Hold" and a consensus price target of $17.22.

Chemours Stock Performance

The company has a market capitalization of $1.83 billion, a price-to-earnings ratio of 60.91 and a beta of 1.65. The company has a debt-to-equity ratio of 7.01, a quick ratio of 0.83 and a current ratio of 1.75. The firm's 50 day simple moving average is $11.23 and its 200-day simple moving average is $14.20.

Chemours (NYSE:CC - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The specialty chemicals company reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.19 by ($0.06). The firm had revenue of $1.37 billion during the quarter, compared to analyst estimates of $1.36 billion. Chemours had a return on equity of 23.82% and a net margin of 0.54%. The company's quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.32 EPS. Analysts expect that The Chemours Company will post 2.03 EPS for the current year.

Chemours Announces Dividend

The company also recently announced a dividend, which was paid on Monday, June 16th. Investors of record on Monday, May 19th were given a $0.0875 dividend. The ex-dividend date of this dividend was Friday, May 16th. This represents a yield of 3.17%. Chemours's dividend payout ratio (DPR) is currently 175.00%.

Insider Activity at Chemours

In other Chemours news, CFO Shane Hostetter purchased 4,450 shares of the firm's stock in a transaction that occurred on Monday, May 19th. The shares were acquired at an average cost of $11.28 per share, for a total transaction of $50,196.00. Following the transaction, the chief financial officer directly owned 59,694 shares in the company, valued at approximately $673,348.32. The trade was a 8.06% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, insider Damian Gumpel acquired 13,400 shares of Chemours stock in a transaction on Monday, June 2nd. The stock was acquired at an average cost of $9.22 per share, for a total transaction of $123,548.00. Following the completion of the purchase, the insider owned 123,879 shares of the company's stock, valued at approximately $1,142,164.38. The trade was a 12.13% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 25,672 shares of company stock valued at $251,573 in the last 90 days. 0.34% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the company. Amalgamated Bank raised its holdings in shares of Chemours by 4.6% in the 4th quarter. Amalgamated Bank now owns 72,714 shares of the specialty chemicals company's stock valued at $1,229,000 after purchasing an additional 3,188 shares during the period. Proficio Capital Partners LLC acquired a new position in Chemours in the fourth quarter valued at about $334,000. LGT Fund Management Co Ltd. boosted its position in shares of Chemours by 12.3% during the 4th quarter. LGT Fund Management Co Ltd. now owns 215,481 shares of the specialty chemicals company's stock worth $3,642,000 after acquiring an additional 23,553 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Chemours by 6.0% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,302,272 shares of the specialty chemicals company's stock valued at $22,008,000 after purchasing an additional 73,220 shares in the last quarter. Finally, Victory Capital Management Inc. grew its position in Chemours by 6.8% in the fourth quarter. Victory Capital Management Inc. now owns 110,311 shares of the specialty chemicals company's stock valued at $1,864,000 after acquiring an additional 7,052 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.